Brain Metastases Prognostic Index

Estimate prognosis in patients with brain metastases using the graded prognostic assessment

The global unit selector only affects unanswered questions
1.Tumor Type?
2.Karnofsky Performance Score (KPS)?
3.Extracranial Metastases?
4.Number of Brain Metastases?
5.Age?
6.If Breast Cancer, cancer subtype?
Created by

1. Tumor Type?

More Information

This tool can be used for non-small cell lung cancer, small cell lung cancer, melanoma, renal cell carcinoma, breast cancer, and gastrointestinal cancer.

Created by
0/6 completed

About this Calculator

Due to significant heterogeneity in survival after brain metastases that depends, in part, on the primary tumor, a diagnosis-specific prognostic index was developed.

The diagnosis-specific graded prognostic assessment (DS-GPA) is based on an analysis of 3940 patients with newly diagnosed brain metastases.

Unique prognostic models were developed for patients with non-small cell lung cancer, small cell lung cancer, melanoma, renal cell carcinoma, breast cancer, and gastrointestinal cancer.

References

Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, Sperduto CM, Lin N, Mehta M.

Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases.

Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2012 February 1, 30 (4): 419-25

Legal Notices and Disclaimer

© 2020 QxMD Software Inc., all rights reserved. No part of this service may be reproduced in any way without express written consent of QxMD. This information should not be used for the diagnosis or treatment of any health problem or disease. This information is not intended to replace clinical judgment or guide individual patient care in any manner. Click here for full notice and disclaimer.